People are turning to drugs like Ozempic and Wegovy to lose weight – but where do they fit in the body-positivity movement? Today on Post Reports, what some fat activists think of these drugs and how one doctor is talking about these medicines with her patients.
Read more:
Some companies are marketing GLP-1 drugs to body-positive influencers in the hopes that they’ll market their products to their followers.
Shane O’Neill is a style reporter at the Post and writes the Style Memo newsletter. When he heard about this marketing push, he reached out to some of these influencers and activists to get their take on whether these drugs had a place in their messaging.
At the same time, many doctors are busy fielding questions from patients who are interested in taking these drugs to lose weight. Mara Gordon is a physician in New Jersey who is trying to stop weight stigma by practicing a size-inclusive approach to medicine – meaning she doesn’t offer these drugs for weight loss. She doesn’t think that these drugs can cure fatphobia, and so she tries to talk through patients' goals with them and orient the solutions away from weight loss.
“So let's say I have a patient who doesn't have diabetes, but they say they want to lose weight. So we try to explore that – what are you hoping to achieve? What feels wrong in your life that feels related to, related to your body size?”
Today’s show was produced by Sabby Robinson. It was edited by Lucy Perkins and mixed by Sean Carter. Thanks to Monica Campbell and Ariel Plotnick.
Subscribe to The Washington Post here.
Inside TikTok's extraordinary almost-deal with the U.S.
The Campaign Moment: The politics of the Trump guilty verdict
Donald Trump, convicted felon
The escalating attacks in Gaza
Get ready for a hot AI summer
India’s historic election
Deep Reads: In Milwaukee, a patio becomes a battleground for Black public housing tenants
The Campaign Moment: Down-ballot Dems try to lift Biden
The ripple effects of the coup in Niger
A vote for the soul of the Republican Party
The Young Thug trial and how it could reshape music
The death of Iran’s president
The Campaign Moment: Trump accepted Biden’s debate proposal. Now what?
What to know about inflation right now
Rethinking identity in a fractured America
The end of Google search as we know it
Is the Drake-Kendrick rap beef good for hip-hop?
The Campaign Moment: Trump trial delays, boos for MTG and Biden’s red line on Rafah
Will U.S. threats change Israel’s war?
Create your
podcast in
minutes
It is Free
The 7
The Daily
Up First
What Next | Daily News and Analysis
Today, Explained